Back to Search
Start Over
Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis.
- Source :
- JEADV Clinical Practice; Sep2023, Vol. 2 Issue 3, p571-575, 5p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 27686566
- Volume :
- 2
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- JEADV Clinical Practice
- Publication Type :
- Academic Journal
- Accession number :
- 171350659
- Full Text :
- https://doi.org/10.1002/jvc2.179